chr17-4945982-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_005022.4(PFN1):c.341T>C(p.Met114Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
PFN1
NM_005022.4 missense
NM_005022.4 missense
Scores
10
6
3
Clinical Significance
Conservation
PhyloP100: 7.67
Genes affected
PFN1 (HGNC:8881): (profilin 1) This gene encodes a member of the profilin family of small actin-binding proteins. The encoded protein plays an important role in actin dynamics by regulating actin polymerization in response to extracellular signals. Deletion of this gene is associated with Miller-Dieker syndrome, and the encoded protein may also play a role in Huntington disease. Multiple pseudogenes of this gene are located on chromosome 1. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM1
In a chain Profilin-1 (size 138) in uniprot entity PROF1_HUMAN there are 5 pathogenic changes around while only 0 benign (100%) in NM_005022.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.949
PP5
Variant 17-4945982-A-G is Pathogenic according to our data. Variant chr17-4945982-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 37035.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-4945982-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFN1 | NM_005022.4 | c.341T>C | p.Met114Thr | missense_variant | 3/3 | ENST00000225655.6 | NP_005013.1 | |
PFN1 | NM_001375991.1 | c.*425T>C | 3_prime_UTR_variant | 2/2 | NP_001362920.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFN1 | ENST00000225655.6 | c.341T>C | p.Met114Thr | missense_variant | 3/3 | 1 | NM_005022.4 | ENSP00000225655.5 | ||
PFN1 | ENST00000574872.1 | c.233T>C | p.Met78Thr | missense_variant | 2/2 | 2 | ENSP00000465019.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Amyotrophic lateral sclerosis type 18 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 23, 2012 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 11, 2021 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects PFN1 function (PMID: 22801503). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 37035). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 22801503). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 114 of the PFN1 protein (p.Met114Thr). - |
PFN1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2023 | The PFN1 c.341T>C variant is predicted to result in the amino acid substitution p.Met114Thr. This variant was reported in an individual(s) with amyotrophic lateral sclerosis (Wu et al. 2012. PubMed ID: 22801503; Corcia et al. 2021. PubMed ID: 33408239). In vitro assays showed p.Met114Thr promotes the formation of PFN1 aggregates and impacts its function (Tanaka et al. 2016. PubMed ID: 26908597). An in vivo fruit fly model suggested the variant may exert a loss-of-function mechanism (Wu et al. 2017. PubMed ID: 28379367) though other studies have suggested a gain-of-function mechanism via formin-induced actin polymerization ultimately resulting in neurodegeneration (Schmidt et al. 2021. PubMed ID: 34074767; Liu et al. 2022. PubMed ID: 35248815) This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;.
REVEL
Pathogenic
Sift
Uncertain
D;.
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Loss of stability (P = 0.1116);.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at